# Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC

> **NCT03734068** · — · UNKNOWN · sponsor: **International Group of Endovascular Oncology** · enrollment: 100 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** Chemoembolization Using LifePearl
- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT03734068
- **Lead sponsor:** International Group of Endovascular Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-13
- **Primary completion:** 2021-06
- **Final completion:** 2021-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03734068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03734068, "Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03734068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*